Equities

PCI Biotech Holding ASA

PCI Biotech Holding ASA

Actions
  • Price (NOK)1.80
  • Today's Change0.00 / 0.00%
  • Shares traded444.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 15 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of NOK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4157116
Total Receivables, Net2.576.1612
Total Inventory------
Prepaid expenses------
Other current assets, total0.00----
Total current assets4463128
Property, plant & equipment, net0.300.727.66
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets--0.00--
Total assets4463136
LIABILITIES
Accounts payable0.710.503.75
Accrued expenses3.073.3714
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.320.440.63
Other current liabilities, total0.871.442.32
Total current liabilities4.975.7521
Total long term debt00.331.28
Total debt0.320.771.91
Deferred income tax------
Minority interest------
Other liabilities, total0.03--0
Total liabilities5.016.0822
SHAREHOLDERS EQUITY
Common stock1.12112112
Additional paid-in capital380450
Retained earnings (accumulated deficit)0(55)(449)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.000.000.00
Total equity3957114
Total liabilities & shareholders' equity4463136
Total common shares outstanding373737
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.